When Lyme disease makes the news, it's typically not for positive reasons — but Pfizer is gearing up to seek regulatory approval for a new vaccine candidate, CNBC reported. In April 2020, Pfizer and ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The FDA recently approved updated 2026-2027 COVID-19 vaccines from Moderna, Pfizer-BioNTech, ...

Comirnaty is an mRNA vaccine that delivers genetic instructions for the SARS-CoV-2 spike protein, prompting the immune system to recognize and respond to the virus, as described by the US Centers for ...

The new 2026-2027 COVID-19 vaccines are available. Experts explain who should get one the shots and why, the best time to get vaccinated, side effects and more.

Four doses of an experimental vaccine to protect against Lyme disease reduced the number of tick-borne infections by more than 70 percent, according to Pfizer and Valneva, the pharmaceutical companies ...

Pfizer CEO Albert Bourla called vaccine skepticism in the highest levels of the federal government “an anomaly” during an investor call on Tuesday. “We will continue investing in vaccines because, as ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. An experimental vaccine from Pfizer and ...

LONDON, April 1 (Reuters) - Vaccine makers Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to ...

People looking to get their annual flu shot this fall may find a new option alongside the usual vaccines: an mRNA flu shot. Not everyone is eligible, however.

Comirnaty is an mRNA vaccine that trains the immune system to recognize the spike protein found on the surface of SARS-CoV-2, the virus that causes COVID-19 CDC, 09/27/2023. The vaccine uses a small ...